ArticleScientific reports2026

Development and validation of pathomics signature for predicting prognosis of advanced high-grade serous ovarian carcinoma patients after platinum-based chemotherapy.

Zhenhong Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.